Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis. (Record no. 19115976)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02101 a2200613 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515184109.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201007s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1536-4844 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1002/ibd.21084 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Baumgart, Daniel C |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20100727 |
| 245 00 - TITLE STATEMENT | |
| Title | Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Inflammatory bowel diseases |
| Date of publication, distribution, etc. | Apr 2010 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 620-9 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adolescent |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adrenal Cortex Hormones |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | CD3 Complex |
| General subdivision | immunology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Colitis, Ulcerative |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Resistance |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Follow-Up Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prospective Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Survival Rate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Targan, Stephan R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dignass, Axel U |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mayer, Lloyd |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van Assche, Gert |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hommes, Daan W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hanauer, Stephen B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mahadevan, Uma |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Reinisch, Walter |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Plevy, Scott E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Salzberg, Bruce A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Buchman, Alan L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mechkov, Grigor M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Krastev, Zahariy A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lowder, James N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Frankel, Matthew B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sandborn, William J |
| 773 0# - HOST ITEM ENTRY | |
| Title | Inflammatory bowel diseases |
| Related parts | vol. 16 |
| -- | no. 4 |
| -- | p. 620-9 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1002/ibd.21084">https://doi.org/10.1002/ibd.21084</a> |
| Public note | Available from publisher's website |
No items available.